FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597269544> ?p ?o ?g. }

• W2597269544 endingPage "34373" @default.
• W2597269544 startingPage "34362" @default.
• W2597269544 abstract "// Heng Zhang 1, 2 , Limei Liu 1 , Chungang Liu 1 , Jinhong Pan 2 , Gensheng Lu 2 , Zhansong Zhou 2 , Zhiwen Chen 2 , Cheng Qian 1 1 Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China 2 Department of Urology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China Correspondence to: Cheng Qian, email: cqian3184@163.com Zhiwen Chen, email: zhiwen@tmmu.edu.cn Keywords: Notch3, urothelial cancer, cisplatin, histone deacetylase, chemoresistance Received: March 14, 2016      Accepted: December 12, 2016      Published: March 13, 2017 ABSTRACT Abnormal activation of Notch signaling is involved in the etiology of various diseases, including cancer, but the association between Notch3 expression in urothelial cancer and clinical outcome remains unclear, and the molecular mechanisms underlying Notch3 signaling activation are not well defined. In this study we examined 59 urothelial cancer patients and found that Notch3 was more highly expressed in human urothelial cancer tissues than in non-tumorous bladder tissue samples, with Notch3 overexpression being associated with poor clinical outcome. Notch3 knockdown resulted in decreased proliferation of urothelial cancer cells in vitro and decreased xenograft tumor growth in vivo . In addition, Notch3 knockdown rendered urothelial cancer cells more sensitive to cisplatin. Furthermore, suberoylanilide hydroxamic acid (SAHA, a histone deacetylase [HDAC] inhibitor) induced acetylation of NOTCH3, downregulated Notch 3 , prevented urothelial cancer cell proliferation, and induced cell cycle arrest. Taken together, these data suggested that Notch 3 overexpression promotes growth and chemoresistance in urothelial cancer." @default.
• W2597269544 created "2017-03-23" @default.
• W2597269544 creator A5003689755 @default.
• W2597269544 creator A5025226017 @default.
• W2597269544 creator A5032377389 @default.
• W2597269544 creator A5034227844 @default.
• W2597269544 creator A5044154626 @default.
• W2597269544 creator A5069417259 @default.
• W2597269544 creator A5083951252 @default.
• W2597269544 creator A5085157497 @default.
• W2597269544 date "2017-03-13" @default.
• W2597269544 modified "2023-09-25" @default.
• W2597269544 title "Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma" @default.
• W2597269544 cites W1486234296 @default.
• W2597269544 cites W1560262279 @default.
• W2597269544 cites W1967018540 @default.
• W2597269544 cites W1970140374 @default.
• W2597269544 cites W1973569665 @default.
• W2597269544 cites W1974567048 @default.
• W2597269544 cites W1985820288 @default.
• W2597269544 cites W1993450184 @default.
• W2597269544 cites W1996470451 @default.
• W2597269544 cites W1999356404 @default.
• W2597269544 cites W2005925039 @default.
• W2597269544 cites W2006292889 @default.
• W2597269544 cites W2008861148 @default.
• W2597269544 cites W2008878539 @default.
• W2597269544 cites W2013588387 @default.
• W2597269544 cites W2020579083 @default.
• W2597269544 cites W2023271047 @default.
• W2597269544 cites W2024987854 @default.
• W2597269544 cites W2025954950 @default.
• W2597269544 cites W2027741880 @default.
• W2597269544 cites W2027787548 @default.
• W2597269544 cites W2032659674 @default.
• W2597269544 cites W2070878701 @default.
• W2597269544 cites W2078744748 @default.
• W2597269544 cites W2088382836 @default.
• W2597269544 cites W2106787323 @default.
• W2597269544 cites W2115504447 @default.
• W2597269544 cites W2117348043 @default.
• W2597269544 cites W2124323423 @default.
• W2597269544 cites W2165812499 @default.
• W2597269544 cites W2233600556 @default.
• W2597269544 cites W2346385903 @default.
• W2597269544 cites W2402565541 @default.
• W2597269544 cites W2408036176 @default.
• W2597269544 cites W2550232866 @default.
• W2597269544 doi "https://doi.org/10.18632/oncotarget.16156" @default.
• W2597269544 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5470974" @default.
• W2597269544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28416766" @default.
• W2597269544 hasPublicationYear "2017" @default.
• W2597269544 type Work @default.
• W2597269544 sameAs 2597269544 @default.
• W2597269544 citedByCount "25" @default.
• W2597269544 countsByYear W25972695442018 @default.
• W2597269544 countsByYear W25972695442019 @default.
• W2597269544 countsByYear W25972695442020 @default.
• W2597269544 countsByYear W25972695442021 @default.
• W2597269544 countsByYear W25972695442022 @default.
• W2597269544 countsByYear W25972695442023 @default.
• W2597269544 crossrefType "journal-article" @default.
• W2597269544 hasAuthorship W2597269544A5003689755 @default.
• W2597269544 hasAuthorship W2597269544A5025226017 @default.
• W2597269544 hasAuthorship W2597269544A5032377389 @default.
• W2597269544 hasAuthorship W2597269544A5034227844 @default.
• W2597269544 hasAuthorship W2597269544A5044154626 @default.
• W2597269544 hasAuthorship W2597269544A5069417259 @default.
• W2597269544 hasAuthorship W2597269544A5083951252 @default.
• W2597269544 hasAuthorship W2597269544A5085157497 @default.
• W2597269544 hasBestOaLocation W25972695441 @default.
• W2597269544 hasConcept C104317684 @default.
• W2597269544 hasConcept C121608353 @default.
• W2597269544 hasConcept C126322002 @default.
• W2597269544 hasConcept C161879069 @default.
• W2597269544 hasConcept C170493617 @default.
• W2597269544 hasConcept C173396325 @default.
• W2597269544 hasConcept C190283241 @default.
• W2597269544 hasConcept C2776694085 @default.
• W2597269544 hasConcept C2778239845 @default.
• W2597269544 hasConcept C2778305200 @default.
• W2597269544 hasConcept C2780352672 @default.
• W2597269544 hasConcept C2910041100 @default.
• W2597269544 hasConcept C502942594 @default.
• W2597269544 hasConcept C54355233 @default.
• W2597269544 hasConcept C55493867 @default.
• W2597269544 hasConcept C555283112 @default.
• W2597269544 hasConcept C62112901 @default.
• W2597269544 hasConcept C64927066 @default.
• W2597269544 hasConcept C71924100 @default.
• W2597269544 hasConcept C86803240 @default.
• W2597269544 hasConceptScore W2597269544C104317684 @default.
• W2597269544 hasConceptScore W2597269544C121608353 @default.
• W2597269544 hasConceptScore W2597269544C126322002 @default.
• W2597269544 hasConceptScore W2597269544C161879069 @default.
• W2597269544 hasConceptScore W2597269544C170493617 @default.
• W2597269544 hasConceptScore W2597269544C173396325 @default.
• W2597269544 hasConceptScore W2597269544C190283241 @default.

• next